Eumovate ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

eumovate

glaxosmithkline nz limited - clobetasone butyrate 0.05%{relative};   - topical cream - 0.05% w/w - active: clobetasone butyrate 0.05%{relative}   excipient: beeswax, synthetic cetostearyl alcohol chlorocresol citric acid monohydrate dimeticone glycerol glyceryl monostearate purified water self-emulsifying glyceryl monostearate sodium citrate dihydrate - short-term (up to 7 days) treatment of milder forms of eczema and dermatitis.

Clomazol 1% ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

clomazol 1%

multichem nz limited - clotrimazole 10 mg/g - vaginal cream - 1% w/w - active: clotrimazole 10 mg/g excipient: benzyl alcohol cetomacrogol 1000 cetostearyl alcohol dimeticone disodium edetate glyceryl monostearate liquid paraffin propylene glycol purified water white soft paraffin - for the topical treatment of vulvovaginal candidiasis. application of the cream to the glans penis of the partner may help prevent re-infection of the female.

Clomazol 2% ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

clomazol 2%

multichem nz limited - clotrimazole 20 mg/g - vaginal cream - 20 mg/g - active: clotrimazole 20 mg/g excipient: benzyl alcohol cetomacrogol 1000 cetostearyl alcohol dimeticone disodium edetate glyceryl monostearate liquid paraffin propylene glycol purified water white soft paraffin - for the topical treatment of vulvovaginal candidiasis. application of the cream to the glans penis of the partner may help prevent re-infection of the female.

Creon Micro ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

creon micro

viatris limited - pancreatin 60.12mg (3,600 ph. eur. u/amylase, 5,000 ph. eur. u/lipase and 200 ph. eur. u/protease) - modified release granules - 60.12 mg - active: pancreatin 60.12mg (3,600 ph. eur. u/amylase, 5,000 ph. eur. u/lipase and 200 ph. eur. u/protease) excipient: cetyl alcohol dimeticone hypromellose phthalate macrogol 4000 triethyl citrate - for treatment of conditions associated with pancreatic exocrine insufficiency, such as: cystic fibrosis, chronic pancreatitis, post-pancreatectomy, post-gastrointestinal bypass surgery, e.g. billroth ii, gastroenterostomy; ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

Duac Once Daily Gel ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

duac once daily gel

glaxosmithkline nz limited - benzoyl peroxide 66.7 mg/g; clindamycin phosphate 12.8 mg/g;   - topical gel - 1%w/w, 5%w/w - active: benzoyl peroxide 66.7 mg/g clindamycin phosphate 12.8 mg/g   excipient: carbomer 940 colloidal silicon dioxide dimeticone disodium edetate dihydrate disodium lauryl sulfosuccinate glycerol poloxamer purified water sodium hydroxide - for the topical treatment of comedo, papular and pustular acne vulgaris.

Eumovate ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

eumovate

glaxosmithkline nz limited - clobetasone butyrate 0.05%{relative};   - topical cream - 0.05% w/w - active: clobetasone butyrate 0.05%{relative}   excipient: beeswax, synthetic cetostearyl alcohol chlorocresol citric acid monohydrate dimeticone glycerol glyceryl monostearate purified water self-emulsifying glyceryl monostearate sodium citrate dihydrate - treatment of atopic eczema, photodermatitis, otitis externa, primary irritant and allergic dermatitis, prurigo nodularis, sevorrhoeic dermatitis, and other steroid responsive skin conditions which do not require the use of a more active topical corticosteroid in children and adults. in the more resistant dermatoses. eumovate may be used as maintenance therapy between courses of one of the more active topical steroids.

Pradaxa ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

pradaxa

boehringer ingelheim (nz) limited - dabigatran etexilate mesylate 126.83mg equivalent to dabigatran etexilate 110 mg;  ;   - capsule - 110 mg - active: dabigatran etexilate mesylate 126.83mg equivalent to dabigatran etexilate 110 mg     excipient: acacia dimeticone hyprolose hypromellose hpmc capsule size 1 - (tt70-14-2-2) purified talc tartaric acid tekprint black sw-9008 - prevention of venous thromboembolic events in patients who have undergone major orthopaedic surgery.

Pradaxa ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

pradaxa

boehringer ingelheim (nz) limited - dabigatran etexilate mesylate 172.95mg equivalent to dabigatran etexilate 150 mg;  ;   - capsule - 150 mg - active: dabigatran etexilate mesylate 172.95mg equivalent to dabigatran etexilate 150 mg     excipient: acacia dimeticone hyprolose hypromellose hpmc capsule size 0 (tt70-14-2-4) purified talc tartaric acid tekprint black sw-9008 - prevention of venous thromboembolic events in patients who have undergone major orthopaedic surgery.

Pradaxa ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

pradaxa

boehringer ingelheim (nz) limited - dabigatran etexilate mesylate 86.48mg equivalent to dabigatran etexilate 75 mg;  ;   - capsule - 75 mg - active: dabigatran etexilate mesylate 86.48mg equivalent to dabigatran etexilate 75 mg     excipient: acacia dimeticone hyprolose hypromellose hpmc capsule size 2 - (tt70-14-2-3) purified talc tartaric acid tekprint black sw-9008 - prevention of venous thromboembolic events in patients who have undergone major orthopaedic surgery.

ATOMOXETINE SANDOZ atomoxetine (as hydrochloride) 100 mg capsule blister pack אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

atomoxetine sandoz atomoxetine (as hydrochloride) 100 mg capsule blister pack

sandoz pty ltd - atomoxetine hydrochloride, quantity: 114.3 mg (equivalent: atomoxetine, qty 114.3 mg) - capsule, hard - excipient ingredients: dimeticone 350; sodium starch glycollate type a; maize starch; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; iron oxide yellow; sorbitan monolaurate; iron oxide red; gelatin; sodium lauryl sulfate - for the treatment of attention deficit hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.